GLP-1, GIP, and Glucagon: Understanding the Science Behind Multi-Receptor Peptides

GLP-1, GIP, and Glucagon: Understanding the Science Behind Multi-Receptor Peptides

Some of the most exciting research in metabolic science centers around three hormones: GLP-1. GIP. Glucagon. Individually, each participates in the complicated biological system controlling glucose, appetite, digestion and energy metabolism. Increasingly, scientists are asking a fascinating question: What happens when one engineered molecule influences two—or even all three—of these receptor systems simultaneously? The answer […]

Continue Reading
Retatrutide Research: What Scientists Are Learning About Triple-Receptor Agonism

Retatrutide Research: What Scientists Are Learning About Triple-Receptor Agonism

Few investigational peptides have generated as much scientific interest in recent years as retatrutide. Retatrutide represents an important evolution in metabolic peptide research because it was engineered to activate not one, not two, but three hormone receptors involved in metabolism: This makes retatrutide a triple hormone receptor agonist. The idea behind this approach is fascinating. […]

Continue Reading
Semaglutide

Semaglutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Semaglutide is a peptide-based medication that has become one of the most important drugs in modern diabetes, obesity, and cardiovascular medicine. It belongs to a class known as GLP-1 receptor agonists, meaning it mimics the activity of the naturally occurring hormone glucagon-like peptide-1, or GLP-1. GLP-1 is released from the gastrointestinal tract after eating and […]

Continue Reading
Tirzepatide

Tirzepatide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Tirzepatide is one of the most important medications to emerge in modern metabolic medicine. It is a once-weekly injectable peptide-based medication that activates two hormone receptors involved in blood sugar control, appetite, and body weight: GIP — glucose-dependent insulinotropic polypeptide and GLP-1 — glucagon-like peptide-1. Because it targets both receptors simultaneously, tirzepatide is commonly described […]

Continue Reading
Cagrilintide

Cagrilintide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Cagrilintide peptide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide peptide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects […]

Continue Reading
Retatrutide

Retatrutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Few experimental metabolic peptides have generated as much attention as retatrutide peptide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide peptide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets […]

Continue Reading